DIVISLAB Divi's Laboratories Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals
Sector: Healthcare · Nifty 50 Weight: 0.45%Live setups screens DIVISLAB is on right now — tap to see every stock matching
Smart Money Verdict synthesis of derivatives, deals, and promoter files
Analysis what the data is telling us about DIVISLAB
In the last completed session, Divi's Laboratories Ltd. closed -2.38% with futures open interest moving +1.2%. That combination — price falling while OI builds — is classified as Short Buildup. Fresh short positions are being added on weakness, which historically prefaces further downside until shorts are forced to cover. The stock's option PCR sits at 0.61, indicating heavy call-side writing — option dealers see resistance overhead. Max-pain strike at ₹9,500 sits 1.5% above the current price, a mild magnet near expiry.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Divi's Laboratories Ltd. over the last 30 sessions.
Putting it together, the smart-money picture for Divi's Laboratories Ltd. points to a softer setup at the next open.
F&O Positioning EOD derivatives setup
Quote Details key metrics & weights
Technical Snapshot as of 2026-10-08 close · from 400 sessions of price history
Key Fundamentals headline ratios · Healthcare
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
Institutional Deals last 30 sessions (bulk & block)
Insider & Promoter Filings last 60 days
Option Chain Ladder nearest expiry 2026-10-27 · spot 9,361 · EOD 2026-10-08
| Call OI (writers) | Strike | Put OI (writers) |
|---|---|---|
| 8800 |
IV 28%
Δ -0.15
θ -3.5
ν 5
|
|
|
IV 40%
Δ 0.74
θ -8.4
ν 7
|
8900 |
IV 28%
Δ -0.19
θ -3.9
ν 6
|
|
IV 28%
Δ 0.76
θ -6.0
ν 7
|
9000 |
IV 27%
Δ -0.24
θ -4.3
ν 7
|
|
IV 27%
Δ 0.71
θ -6.3
ν 7
|
9100 |
IV 27%
Δ -0.29
θ -4.6
ν 7
|
|
IV 27%
Δ 0.64
θ -6.6
ν 8
|
9200 |
IV 26%
Δ -0.35
θ -4.9
ν 8
|
|
IV 26%
Δ 0.58
θ -6.7
ν 8
|
9300 |
IV 26%
Δ -0.42
θ -5.0
ν 8
|
|
IV 26%
Δ 0.51
θ -6.7
ν 9
|
9400 |
IV 26%
Δ -0.49
θ -4.9
ν 9
|
|
IV 26%
Δ 0.44
θ -6.5
ν 8
|
9500 MP |
IV 26%
Δ -0.56
θ -4.7
ν 8
|
|
IV 26%
Δ 0.37
θ -6.2
ν 8
|
9600 |
IV 26%
Δ -0.63
θ -4.4
ν 8
|
|
IV 26%
Δ 0.31
θ -5.7
ν 8
|
9700 |
IV 26%
Δ -0.70
θ -3.9
ν 7
|
|
IV 27%
Δ 0.25
θ -5.2
ν 7
|
9800 |
IV 27%
Δ -0.75
θ -3.4
ν 7
|
|
IV 27%
Δ 0.20
θ -4.6
ν 6
|
9900 |
IV 26%
Δ -0.80
θ -2.7
ν 6
|
|
IV 27%
Δ 0.16
θ -4.0
ν 5
|
10000 R |
IV 26%
Δ -0.85
θ -1.9
ν 5
|
Chain Interpretation
Strategy Builder multi-leg payoff for DIVISLAB options · 2026-10-27 expiry
Legs
Payoff at expiry
Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others
DIVISLAB — frequently asked questions
What is the Divi's Laboratories Ltd. share price today?
DIVISLAB is trading at ₹9,361.00 (-2.37% vs previous close), per the latest update on this page.
What is the P/E ratio of Divi's Laboratories Ltd.?
DIVISLAB (Divi's Laboratories Ltd.) has a trailing twelve-month P/E ratio of 84.9.
What is the market cap of Divi's Laboratories Ltd.?
DIVISLAB has a market capitalisation of approximately ₹248,505 crore.
Is DIVISLAB near its 52-week high?
DIVISLAB is trading -3.9% from its 52-week high of ₹9,740.00 as of 2026-10-08.
What is the RSI of DIVISLAB?
The 14-day RSI of DIVISLAB is 53.0, which is considered neutral.
Is DIVISLAB above its 200-day moving average?
DIVISLAB is trading above its 200-DMA of ₹7,132.02 (+31.2% away).
What is the F&O buildup in DIVISLAB?
The latest end-of-day derivatives data classifies DIVISLAB as Short Buildup (bias: bearish), based on the day's combined price and open-interest change.
What is the max pain and PCR for DIVISLAB options?
DIVISLAB's option-chain max pain strike is ₹9,500 and its put-call ratio (OI) is 0.61, from the latest end-of-day option chain.
Are FIIs or big investors buying DIVISLAB?
Strota tracks every bulk and block deal in DIVISLAB with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.